Results 31 to 40 of about 5,158 (243)

Headache in individuals undergoing hormone therapy for gender transition: A cross‐sectional, observational study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the prevalence, frequency, and characteristics of headache disorders in transgender individuals receiving gender‐affirming hormone therapy (GAHT), and to explore the relationship between GAHT and headache pathophysiology.
Lucia Jimena Zavala   +4 more
wiley   +1 more source

False nonresponders to anti‐calcitonin gene‐related peptide monoclonal antibodies: A real‐world analysis beyond migraine frequency reduction

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Reimbursement criteria for anti‐calcitonin gene‐related peptide (CGRP) monoclonal antibodies (MAbs) typically rely on predefined reductions in monthly migraine days (MMD). However, this approach may fail to capture the full spectrum of treatment benefits, potentially leading to premature discontinuation in patients ...
Albert Muñoz‐Vendrell   +7 more
wiley   +1 more source

Narcotic analgesics for acute migraine in the emergency room: are we meeting headache societies\u27 guidelines? [PDF]

open access: yes, 2006
We analysed 161 patients with acute migraine in our emergency room (ER) to identify the use of narcotic analgesics as first-line treatment. Twenty-four percent of patients were treated with opioid analgesics and 76% patients were treated with non-opioid ...
Khan, Saqib Uddin   +3 more
core   +2 more sources

Gepants, calcitonin gene-related peptide antagonists, for abortive treatment of migraine: current status [PDF]

open access: yes, 2021
Migraine is a neurovascular disorder characterized by unilateral, recurrent, pulsating, throbbing, and moderate to severe headache. Triptans use is often limited by their poor efficacy, reports of poor responders, and contraindicated in patients with ...
Gaddam, Soni, Padi, Satyanarayana S. V.
core   +2 more sources

A Review of Nanoparticle‐Based Astrocyte Modulation in CNS Disorders: Evaluating the Underexplored Potential of Intranasal Delivery

open access: yesNano Select, Volume 7, Issue 1, January 2026.
Nanoparticle‐driven nose‐to‐brain drug delivery offers a noninvasive approach to bypass the blood–brain barrier (BBB) and directly modulate reactive astrocytes in CNS disorders. This review highlights biodegradable nanoparticles for astrocyte modulation, enhancing drug bioavailability, sustained release, and neuroinflammation control.
Senamile M. Dlamini   +3 more
wiley   +1 more source

Is Exercise Safe and Effective at Decreasing the Incidence of Tension-Type Headaches? [PDF]

open access: yes, 2011
OBJECTIVE: To determine whether exercise is safe and effective at lowering the incidence of tension-type ...
Pessolano, Ashley
core   +1 more source

Migraine and risk of stroke [PDF]

open access: yes, 2020
Migraine and stroke are two common and heterogeneous neurovascular disorders responsible for a significant burden for those affected and a great economic cost for the society.
Dodick, David W.   +3 more
core   +1 more source

Drug Therapy for Migraine

open access: yes, 2007
Migraine significantly disturbs the quality of life of the patients by causing severe throbbing headache associated with neurological, autonomic, and gastrointestinal symptoms.
C. Chung
semanticscholar   +1 more source

Cordyceps sinensis (CS) Alleviates Chronic Obstructive Pulmonary Disease Symptoms (COPD) by Targeting Inflammation, Apoptosis, and Oxidative Stress Through Ingredient–Gene–Disease Interaction

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 12, December 2025.
Our findings indicate that Cordyceps Sinensis (CS) alleviates COPD symptoms by inhibiting inflammation and oxidative stress, with key biomarkers such as interleukins (ILs), tumor necrosis factor (TNF), and reactive oxygen species (ROS) identified. Activating autophagy serves as a protective mechanism against COPD development induced by oxidative stress.
Zirui Zang, Yuhan Kong, Qi Kong
wiley   +1 more source

Medication-overuse headache

open access: yesLiječnički vjesnik, 2020
Medication-overuse headache (MOH) is a common neurologic disorder with enormous disability and suffering and plays a significant role in the transformation from episodic to chronic headache disorders. Multiple terms have been used to describe MOH such as
Michelle A. Fischer, Arif Jan
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy